Warning letter
Stat Rx USA: warning letter of Oct 9, 2012
FDA warning letter 298059 · Atlanta District Office
Key facts
| Reference number | 298059 |
|---|---|
| Company | Stat Rx USA |
| Subject | CGMP/Finished Pharmaceuticals/Adulterated/Misbranded |
| Issue date | Oct 9, 2012 |
| Posted date | Oct 9, 2012 |
| Issuing office | Atlanta District Office |
| Product type | Drugs |
| CFR sections cited | 211.204, 211.166(a), 211.170(b) |
| Inspection city | Gainesville |
| Inspection ZIP | 30501 |
| Inspection start date | Feb 7, 2012 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: